Literature DB >> 23754243

Test-retest reliability of the disease activity score 28 CRP (DAS28-CRP), the simplified disease activity index (SDAI) and the clinical disease activity index (CDAI) in rheumatoid arthritis when based on patient self-assessment of tender and swollen joints.

Cecilie Heegaard1, Lene Dreyer, Charlotte Egsmose, Ole Rintek Madsen.   

Abstract

Composite disease activity scores are frequently used in daily practice as tools for treatment decisions in patients with rheumatoid arthritis (RA). If reliable, patient-reported disease activity may be time saving in the busy clinic. The objective was to examine the test-retest reliability of the Disease Activity Score 28 CRP (DAS28-CRP) with four variables (4v) and three variables (3v), the Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI) when based on patient self-assessment of tender and swollen joints and to examine the agreement between these scores and physician-derived scores. Thirty out-clinic RA patients with stable disease were included. A joint count was performed two times 1 week apart by the patient and by an experienced physician. Test-retest reliability was expressed as the least significant difference (LSD), as the LSD in percent of the mean score (%LSD) and as intra-individual coefficients of variation (CVi). Mean scores based on physician vs. patient joint counts (visit 1) were: DAS28-CRP(4v) 3.5 ± 1.0 vs. 3.6 ± 1.1 (not significant (NS)), DAS28-CRP(3v) 3.4 ± 0.9 vs. 3.5 ± 0.9 (NS), SDAI 14.2 ± 9.4 vs.14.1 ± 9.4 (NS) and CDAI 13.4 ± 9.3 vs. 13.3 ± 9.4 (NS). The LSDs (%LSD) for duplicate assessments of patient-derived scores (visit 2 vs. 1) were: DAS28-CRP(4v) 0.8 (23.2), DAS28-CRP(3v) 0.9 (25.2), SDAI 8.3 (59.9) and CDAI 8.4 (63.8). Similar LSDs were found for differences between duplicate assessments of physician-derived scores and for differences between physician and patient-derived scores. CVis for SDAI and CDAI were significantly higher than for DAS28-CRP(4v) and DAS28-CRP(3v) (p < 0.005). Patient- and physician-derived scores agreed closely on group level. On the individual level, the LSDs between patient- and physician-derived scores were considerable but corresponded to both patient and physician intra-observer LSDs. Thus, scores based on patient-performed joint counts may be an alternative to traditional physician-derived scores in patients with stable disease.

Entities:  

Mesh:

Year:  2013        PMID: 23754243     DOI: 10.1007/s10067-013-2300-9

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  20 in total

1.  Consistency in assessing the Disease Activity Score-28 in routine clinical practice.

Authors:  C A E Walsh; R H Mullan; P B Minnock; C Slattery; O FitzGerald; B Bresnihan
Journal:  Ann Rheum Dis       Date:  2008-01       Impact factor: 19.103

2.  Measurement error.

Authors:  J M Bland; D G Altman
Journal:  BMJ       Date:  1996-09-21

3.  Measurement error and correlation coefficients.

Authors:  J M Bland; D G Altman
Journal:  BMJ       Date:  1996-07-06

4.  Trunk extensor and flexor strength measured by the Cybex 6000 dynamometer. Assessment of short-term and long-term reproducibility of several strength variables.

Authors:  O R Madsen
Journal:  Spine (Phila Pa 1976)       Date:  1996-12-01       Impact factor: 3.468

5.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

6.  Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

Authors:  M L Prevoo; M A van 't Hof; H H Kuper; M A van Leeuwen; L B van de Putte; P L van Riel
Journal:  Arthritis Rheum       Date:  1995-01

7.  Comparison of anti-TNF treatment initiation in rheumatoid arthritis databases demonstrates wide country variability in patient parameters at initiation of anti-TNF therapy.

Authors:  Chris Pease; Janet E Pope; Don Truong; Claire Bombardier; Jessica Widdifield; J Carter Thorne; Boulos Paul Haraoui; Eliofotisti Psaradellis; John Sampalis; Ashley Bonner
Journal:  Semin Arthritis Rheum       Date:  2010-12-17       Impact factor: 5.532

8.  Test-retest reliability of disease activity core set measures and indices in rheumatoid arthritis.

Authors:  T Uhlig; T K Kvien; T Pincus
Journal:  Ann Rheum Dis       Date:  2008-10-28       Impact factor: 19.103

Review 9.  Systematic review and metaanalysis of patient self-report versus trained assessor joint counts in rheumatoid arthritis.

Authors:  Jennifer L Barton; Lindsey A Criswell; Rachel Kaiser; Yea-Hung Chen; Dean Schillinger
Journal:  J Rheumatol       Date:  2009-11-16       Impact factor: 4.666

10.  Access to biologic treatment for rheumatoid arthritis in Central and Eastern European (CEE) countries.

Authors:  Ewa Orlewska; Ioan Ancuta; Branimir Anic; Catalin Codrenau; Nemanja Damjanov; Predrag Djukic; Ruxandra Ionescu; Lubomir Marinchev; Evgeny L Nasonov; Tonu Peets; Sonja Praprotnik; Rasho Rashkov; Jana Skoupa; Witold Tlustochowicz; Malgorzata Tlustochowicz; Matija Tomsic; Tiina Veldi; Jelena Vojinovic; Piotr Wiland
Journal:  Med Sci Monit       Date:  2011-04
View more
  7 in total

1.  The genetics of rheumatoid arthritis: new insights and implications.

Authors:  David T Felson; Lars Klareskog
Journal:  JAMA       Date:  2015-04-28       Impact factor: 56.272

2.  Stability of clinical outcome measures in rheumatoid arthritis patients with stable disease defined on the basis of the EULAR response criteria.

Authors:  Ole Rintek Madsen
Journal:  Clin Rheumatol       Date:  2016-06-09       Impact factor: 2.980

3.  FRAX fracture risk in women with a recent fracture of the distal forearm: agreement between assessments with and without bone mineral density and impact of measurement side in the individual patient.

Authors:  Emilie Lund Egsmose; Mette Birkvig; Thora Buhl; Ole Rintek Madsen
Journal:  Clin Rheumatol       Date:  2014-05-14       Impact factor: 2.980

4.  High Level Serum Procalcitonin Associated Gouty Arthritis Susceptibility: From a Southern Chinese Han Population.

Authors:  Wen Liu; Keshav Raj Sigdel; Ying Wang; Qun Su; Yan Huang; Yan Lin Zhang; Jie Chen; Lihua Duan; Guixiu Shi
Journal:  PLoS One       Date:  2015-07-16       Impact factor: 3.240

5.  Patient Reported Outcome Measures for Rheumatoid Arthritis Disease Activity: a systematic review following COSMIN guidelines.

Authors:  Tim Pickles; Rhiannon Macefield; Olalekan Lee Aiyegbusi; Claire Beecher; Mike Horton; Karl Bang Christensen; Rhiannon Phillips; David Gillespie; Ernest Choy
Journal:  RMD Open       Date:  2022-03

Review 6.  Toward Overcoming Treatment Failure in Rheumatoid Arthritis.

Authors:  Zhuqian Wang; Jie Huang; Duoli Xie; Dongyi He; Aiping Lu; Chao Liang
Journal:  Front Immunol       Date:  2021-12-23       Impact factor: 7.561

7.  Systematic review of patient-reported outcome measures (PROMs) for assessing disease activity in rheumatoid arthritis.

Authors:  Jos Hendrikx; Marieke J de Jonge; Jaap Fransen; Wietske Kievit; Piet Lcm van Riel
Journal:  RMD Open       Date:  2016-08-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.